Keyphrases
Metformin
100%
Population-based Study
100%
Immediate Release
100%
Sustained-release Formulation
100%
Tayside
9%
Type 2 Diabetes Prevention
9%
Glycemic Control
9%
Retrospective Observational Study
9%
Hemoglobin A1c (HbA1c)
9%
Once a Day
9%
Macrovascular Disease
9%
Intolerant
9%
Glycated Hemoglobin
9%
Gastrointestinal Side Effects
9%
Adherence to Therapy
9%
Glucophage
9%
HbA1c Reduction
9%
Microvascular Disease
9%
Oral Agents
9%
Medicine and Dentistry
Glycon
100%
Sustained Drug Release
100%
Hemoglobin A1c
16%
Observational Study
8%
Maturity Onset Diabetes of the Young
8%
Macrovascular Disease
8%
Glycemic Control
8%
Glycated Hemoglobin
8%
Gastrointestinal Distress
8%
Patient Compliance
8%
Microangiopathy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Metformin
100%
Sustained Release
100%
Hemoglobin A1c
16%
Disease
8%
Glycosylated Hemoglobin
8%
Observational Study
8%
Gastrointestinal Symptom
8%
Non Insulin Dependent Diabetes Mellitus
8%
Nursing and Health Professions
Metformin
100%
Sustained Release Formulation
100%
Hemoglobin A1c
16%
Disease
8%
Non Insulin Dependent Diabetes Mellitus
8%
Glycosylated Hemoglobin
8%
Patient Compliance
8%
Gastrointestinal Symptom
8%